ArticleDrug design, development and therapy2018

Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.

Hongen Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.